Cargando…
Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
Lee Schwartzberg, MD, FACP, and Heather Greene, MSN, FNP, AOCNP®, reviewed optimal therapy for patients with hormone receptor–positive, HER2-negative breast cancer, as well as the management of adverse events associated with treatment.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press LLC
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857322/ https://www.ncbi.nlm.nih.gov/pubmed/33598325 http://dx.doi.org/10.6004/jadpro.2020.11.3.12 |